Could this Llama-Inspired Nanobody Help Curtail COVID?
A UCSF team has engineered a tiny antibody capable of neutralizing the coronavirus.
![Illustration of a person using a handheld nebulizer inhaler; SARS-CoV-2 cells are floating in the background and bubble surround some of their ACE2 receptors.](/sites/default/files/styles/news_card__image/public/2021-01/aeronabs-inhaler-kouzou-sakai-featured.jpg)
University of California San Francisco
Give to UCSFA UCSF team has engineered a tiny antibody capable of neutralizing the coronavirus.
“It’s too soon to know if this variant will spread more rapidly than others," said Erica Pan, MD, MPH, State Epidemiologist for the California Department of Public Health.
UCSF and BridgeBio Pharma, Inc. today announced a partnership to drive the advancement of academic innovations in genetically driven diseases into potential therapeutics for patients.
Patterns of brain activity can be used to forecast seizure risk in epilepsy patients several days in advance, according to a new analysis of data obtained from clinically approved brain implants by neuroscientists at UCSF, the University of Bern and the University of Geneva.
The device, which may be a better illness indicator than a thermometer, could lead to earlier isolation and testing, curbing the spread of infectious diseases.
Finding medicines that can kill cancer cells while leaving normal tissue unscathed is a Holy Grail of oncology research.
A new, $9 million grant from the National Cancer Institute to increase ethnic diversity will help the study work toward a goal of enrolling 100,000 or more women overall.
UC San Francisco’s Center for Digital Health Innovation (CDHI), Fortanix, Intel, and Microsoft Azure have formed a collaboration to establish a confidential computing platform with privacy-preserving
The John and Marcia Goldman Foundation, a private family foundation based in San Francisco, recently granted The Kidney Project $1 million to advance its bioartificial kidney.
Movement timelines from cellphone data can help people who have just received a positive test result recall where they have been and who they came into contact with when they were most infectious.
UCSF Osher Center faculty member Ashley Mason, PhD, has received a $5.1M award to expand TemPredict, a study she directs in collaboration with Rick Hecht, MD, and Benjamin Smarr, PhD.
Researchers at UCSF have developed a “digital biomarker” that would use a smartphone’s built-in camera to detect diabetes.
UCSF scientists have devised a novel approach to halting the spread of SARS-CoV-2, the virus that causes the disease.
As the United States’ testing regime floundered early in the pandemic, scientists at UCSF and the Chan Zuckerberg Biohub created from scratch a diagnostic lab that became a model for the nation.